Formulation and Development of Novel Insitu Nasal Gel Containing Glibenclamide Nanoparticles
To provide an alternative route (non-swallowing) and compliance to patient (controlled release), nasal delivery of sulfonylureas is one of the best option among other routes for type II diabetes. Glibenclamide was selected as a model [...]